Multi-Cancer Vaccine Singapore: NUS NICER Nanovaccine Progress | AcademicJobs
Singapore researchers at NUS advance multi-cancer vaccine development with NICER nanovaccine, targeting cancer stem cells to prevent recurrence.
cancer-vaccineimmunotherapyhigher-education-news

